NAPIGEN
Business Services · Delaware, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
200 Powder Mill Rd Disi-e400, Wilmington...Phone Number
(302) 644-5464Website
www.napigen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About NAPIGEN
NAPIGEN was founded in 2016 by Dr. Hajime Sakai, who has more than 18 years of experience in agricultural R&D at DuPont Pioneer; University of California, Berkeley professor and entrepreneur Dr. Jay Keasling; venture capitalist and agriculture industry veteran Dr. Ganesh Kishore; and venture investor and former dean of agriculture Dr. Roger Wyse. The company is backed with initial funding from the Grantham Foundation, Breakout Labs, Thrive SVG, the State of Delaware, and individual investor and former DuPont executive Jim Borel.Explore more
NAPIGEN Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NAPIGEN your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on NAPIGEN recently announced quarterly report
Click to see if NAPIGEN had a recent Job posting/layoffs
Product Launch: Get notified when NAPIGEN launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once NAPIGEN has new funding data
Congratulate Masked Content for being promoted to Masked Content at NAPIGEN
NAPIGEN, which may be a good buyer, showed buying intent in Masked Content Topic
Check if NAPIGEN has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if NAPIGEN is spiking on competitors!
Recommended Actions
Find VP level buyers at NAPIGEN
Find 3 more new buyers
Compare Similar Companies to NAPIGEN
Compare insights from companies similar to NAPIGEN, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NAPIGEN is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NAPIGEN is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NAPIGEN.
NAPIGEN financials insights
Gather financial insights about NAPIGEN, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$72K
2022
Angel/Seed
$7.8M
NAPIGEN Tech Stack
A closer look at the technologies used by NAPIGEN
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Funding
NAPIGEN has received an SBA PPP loan in the amount of $72,700 from Citizens Bank resulting in the retention of 9 jobs.
Funding
NAPIGEN News & Media
NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant - Yahoo Finance
WILMINGTON, Del., March 11, 2024 (GLOBE NEWSWIRE) -- The U.S. Patent and Trademark Office has issued a patent, US11920140, for the use of CRISPR technologies to edit organellar genomes to NAPIGEN, Inc., a biotechnology company that specializes in mitochondrial and chloroplast genome engineering. The patented claims of US11920140 are directed to methods for altering the genomes of mitochondria or plastids. The mitochondria, also known as the powerhouses of cells, are critical components of plant,Wilson Sonsini Advises NAPIGEN on $7.85 Million Seed Financing
On July 12, 2022, NAPIGEN, a company developing proprietary technology to edit mitochondrial and chloroplast genomes, announced the completion of $7.85 million seed funding round. Grantham Foundation and RA Capital Management led the financing with additional participation from Breakout Labs/Thiel Foundation, Thrive SVG Ventures, MARSBIO, and the United Mitochondrial Disease Foundation. Wilson…NAPIGEN Completes $7.85 Million Funding Round to Advance Its Mitochondrial and Chloroplast Gene Editing Technology
Funds will be used to develop hybrid seed technology in wheat and rice through gene editing of plant mitochondria Funds will be used to develop hybrid seed technology in wheat and rice through gene editing of plant mitochondriaNAPIGEN Publication Provides Proof of Concept of its Technology for Editing Cytoplasmic Genome (Mitochondrial and Chloroplast Genome)
Approach expected to have broad applications in agriculture, industrial biotechnology, human healthcare Approach expected to have broad applications in agriculture, industrial biotechnology, human healthcare
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding NAPIGEN
Sign Up For FreeTo access detailed company insights
NAPIGEN was founded in 2016 by Dr. Hajime Sakai, who has more than 18 years of experience in agricultural R&D at DuPont Pioneer; University of California, Berkeley professor and entrepreneur Dr. Jay Keasling; venture capitalist and agriculture industry veteran Dr. Ganesh Kishore; and venture investor and former dean of agriculture Dr. Roger Wyse. T... Read More
